CORD-19:ee0a7632371a08727d41e55aad7d621daeceef7d / 662546-662718 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T95720","span":{"begin":0,"end":172},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Our results support the finding that polysomy of chromosome 17 is indeed a rare event in breast cancers and increased CEP17 signals indicates pericentromeric amplification."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T178","span":{"begin":0,"end":172},"obj":"Sentence"}],"text":"Our results support the finding that polysomy of chromosome 17 is indeed a rare event in breast cancers and increased CEP17 signals indicates pericentromeric amplification."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T1387","span":{"begin":89,"end":103},"obj":"Phenotype"}],"attributes":[{"id":"A1387","pred":"hp_id","subj":"T1387","obj":"http://purl.obolibrary.org/obo/HP_0003002"}],"text":"Our results support the finding that polysomy of chromosome 17 is indeed a rare event in breast cancers and increased CEP17 signals indicates pericentromeric amplification."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T575","span":{"begin":89,"end":95},"obj":"Body_part"}],"attributes":[{"id":"A575","pred":"uberon_id","subj":"T575","obj":"http://purl.obolibrary.org/obo/UBERON_0000310"}],"text":"Our results support the finding that polysomy of chromosome 17 is indeed a rare event in breast cancers and increased CEP17 signals indicates pericentromeric amplification."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T3132","span":{"begin":89,"end":103},"obj":"Disease"},{"id":"T98370","span":{"begin":89,"end":103},"obj":"Disease"}],"attributes":[{"id":"A3132","pred":"mondo_id","subj":"T3132","obj":"http://purl.obolibrary.org/obo/MONDO_0007254"},{"id":"A11841","pred":"mondo_id","subj":"T98370","obj":"http://purl.obolibrary.org/obo/MONDO_0007254"}],"text":"Our results support the finding that polysomy of chromosome 17 is indeed a rare event in breast cancers and increased CEP17 signals indicates pericentromeric amplification."}